ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2025 Earnings Call Transcript March 17, 2026 ClearPoint Neuro, Inc. misses on ...

Thank you. This is one of the largest unmet needs in all of medicine, and we at ClearPoint Neuro, Inc. believe we can play a ...

The 2025 revenue growth was driven by a 10% increase in biologics and drug delivery as pharmaceutical partners advanced ...

Detailed price information for Clearpoint Neuro Inc (CLPT-Q) from The Globe and Mail including charting and trades.

Greetings, and welcome to the ClearPoint Neuro, Inc. Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this con ...

Explore how the ACCA’s latest report is reshaping neurodiversity in the UK accountancy profession. Learn how firms can unlock ...

Since 2020, more than 100 companies have relocated to Texas—40 percent of them from California, as reported by KERA News. Ten ...

Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to announce that ...

Hyperfine, Inc. (NASDAQ:HYPR) Q4 2025 Earnings Call Transcript March 18, 2026 Hyperfine, Inc. beats earnings expectations.

Q4 2025 Earnings Call March 18, 2026 4:30 PM EDTCompany ParticipantsMaria Sainz - CEO, President & DirectorBrett Hale - ...

Natus Medical Incorporated has announced the global launch of the autoSCORE(TM) analysis tool, spreading the availability of the first artificial-intelligence model capable of automatic and ...

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging ...